Cinnamoyl-piperazine derivatives and their use as PAR-1 antagonists

Details for Australian Patent Application No. 2007263051 (hide)

Owner Pierre Fabre Medicament

Inventors Le Grand, Bruno; Lamothe, Marie; Perez, Michel; Letienne, Robert

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007263051 (Modified Examination)

PCT Pub. Number WO2007/147824

Priority 0605419 19.06.06 FR

Filing date 19 June 2007

Wipo publication date 27 December 2007

Acceptance publication date 20 October 2011

International Classifications

C07D 295/18 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

22 January 2009 PCT application entered the National Phase

  PCT publication WO2007/147824 Priority application(s): WO2007/147824

20 October 2011 Application Accepted

  Published as AU-B-2007263051 (Modified Examination)

16 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007263058-Pyrrolidine derivatives having activity at the GLyT1 transporter

2007263049-Phenylpentadienoyl derivatives and their use as par 1 antagonists